Differentiation of Mesenchymal Stem Cells Derived from Embryonic Umbilical Cord Blood (UCB-MSCs) Into Fibroblastic Lineage for Use as Skin Grafts in Trinidad and Tobago
DOI:
https://doi.org/10.14738/bjhmr.111.15949Keywords:
Mesenchymal Cells, Umblical Cord Blood, Embryonic Stem cells, Cellular Differentiation, Skin GraftsAbstract
The application of stem cells to medical therapies for example regenerative medicine and tissue engineering offers the prospect of revolutionizing human medicine. Burn and wound healing treatment options are very limited in Trinidad and Tobago resulting in a high morbidity/mortality rate of patients. Skin grafts produced from mesenchymal stem cells (MSCs) provide an exciting alternative as an option. This project describes isolation of embryonic MSCs from human umbilical cord blood (UCB-MSCs) and MSCs from bone marrow. We also for the first time in Trinidad and Tobago were able to differentiate UCB-MSCs into fibroblastic lineage cells culture and differentiation into epidermal tissue. Comparison in MSCs obtained will be made between age, ethnicity, and length of gestation to determine correlations. This would provide the basis for using these as a source for skin grafts comparable to allogenic grafts. The results of this project show that human umbilical cord blood is an excellent source of mesenchymal stem cells and that UCB- derived MSCs can be stimulated to differentiate into cells of the epidermal lineage and grown on scaffolding. This preliminary research will be used as a basis for developing skin grafts artificially by differentiation of MSCs into epidermal tissue for application as skin grafts for the treatment of burn victims and for wound healing and/or skin disorders in Trinidad and Tobago.
References
Hu, Y., Rao, S. S., Wang, Z. X., Cao, J., Tan, Y. J., Luo, J., ... & Xie, H. (2018). Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function. Theranostics, 8(1), 169.
Zhou, H., Wang, L., Zhang, C., Hu, J., Chen, J., Du, W., ... & Quan, R. (2019). Feasibility of repairing fullthickness skin defects by iPSC-derived epithelial stem cells seeded on a human acellular amniotic membrane. Stem Cell Research & Therapy, 10(1), 1-13.
Teleb RS, Abdul-Hafez A, Othman A, Ahmed AE, Elsaid AA, Arif H, Zarea AA, Abdulmageed M, Mohamed H, Ibrahim SA, Thiruvenkataramani RP. Cord Blood Plasma and Placental Mesenchymal Stem Cells-Derived Exosomes Increase Ex Vivo Expansion of Human Cord Blood Hematopoietic Stem Cells While Maintaining Their Stemness. Cells. 2023 Jan 7;12(2):250.
Park YB, Lee HJ, Nam HC, Park JG. Allogeneic Umbilical Cord-Blood-Derived Mesenchymal Stem Cells and Hyaluronate Composite Combined with High Tibial Osteotomy for Medial Knee Osteoarthritis with Full-Thickness Cartilage Defects. Medicina. 2023 Jan;59(1):148.
Yang J, Xiao M, Ma K, Li H, Ran M, Yang S, Yang Y, Fu X, Yang S. Therapeutic effects of mesenchymal stem cells and their derivatives in common skin inflammatory diseases: Atopic dermatitis and psoriasis. Frontiers in Immunology. 2023;14.
Zakeri A, Khaseb S, Rahnama MA, Hajaliaskari A, Zomorod MS. Exosomes derived from mesenchymal stem cells: A promising cell-free therapeutic tool for cutaneous wound healing. Biochimie. 2023 Jan 18.
Lakhan, N.A., Mungal, K., Hosein, L.S., and Ramlachan, N. 2013. Development of skin grafts for burn victims from Embryonic Umbilical Cord Blood. Research Symposium, University of Trinidad and Tobago. Aug 21st 2013. NAPA, POS, Trinidad
Mungal, K. Sahadeo, N., Cuthbert C., J.M. Foster., N. Ramlachan. 2012. Growth and differentiation of Mesenchymal Stem Cells Derived from Embryonic Cord Blood for use as potential skin grafts in Trinidad and Tobago. Biotechnologia 2012. Medical Applications of Biotechnology, Havana, Cuba March 5-8 2012.
Lakhan, N., Sahadeo, N., Cuthbert, C., Foster, J. and Ramlachan, N. 2015. Differentiation of Mesenchymal Stem Cells derived from Embryonic Umbilical Cord Blood. World Stem Cell Summit and REGMED Capital Conference, Dec. 10-12, Atlanta, GA USA
Ramlachan, N. Adult Stem Cell Reprogramming for skin grafting using cord blood: a Trinidad and Tobago case study. 2016. World Stem Cell Summit, Dec. 6-9, West Palm Beach, FL USA
Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood, The Journal of the American Society of Hematology. 2013 Jul 25;122(4):491-8.
Liu, J., Sun, W., Liu, C., & Na, Q. (2023). Umbilical Cord Blood-Derived Exosomes in Maternal–Fetal Disease: A Review. Reproductive Sciences, 30(1), 54-61.
Ramcharan R, Dass S, Romany S, Mohammed F, Ali T, Ragbir M. Epidemiology of adult burns in North Trinidad. Internet J Caribb Third World Med. 2003; 1:1.
Ramlachan, N. Sahadeo, N.K., Cuthbert C., J.M. Foster., N. Ramlachan. 2015. Ethnic bias in Differentiation and Characterization of Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Usage in Grafting and Wound Repair. Technical Report, Ministry of Health.
Hsu, J., Van Besien, K., Glesby, M. J., Pahwa, S., Coletti, A., Warshaw, M. G., ... & Yin, D. (2023). HIV-1 remission and possible cure in a woman after haplo-cord blood transplant. Cell, 186(6), 1115-1126. 119
Ahuja A, Tyagi PK, Kumar M, Sharma N, Prakash S, Radha, Chandran D, Dhumal S, Rais N, Singh S, Dey A. Botanicals and Oral Stem Cell Mediated Regeneration: A Paradigm Shift from Artificial to Biological Replacement. Cells. 2022 Sep 7;11(18):2792.
Mao J, Saiding Q, Qian S, Liu Z, Zhao B, Zhao Q, Lu B, Mao X, Zhang L, Zhang Y, Sun X. Reprogramming stem cells in regenerative medicine. Smart Medicine. 2022 Dec;1(1): e20220005.
Wagner JE, Broxmeyer HE, Byrd RL, Zehnbauer B, Schmeckpeper B, Shah N, Griffin C, Emanuel PD, Zuckerman KS, Cooper S. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment (1992): 1874-1881
Central Intelligence Agency World Factbook, "Trinidad and Tobago Demographics Profile 2021."https://www.cia.gov/the-world-factbook/countries/trinidad-and-tobago/
McGuckin C, Forraz N, Baradez MO, Basford C, Dickinson A, Navran S. Embryonic-like stem cells from umbilical cord blood and potential for neural modeling. Acta neurobiologiae experimentalis. 2006;66(4):321-9.
United Nations Children Education Fund (UNICEF) URL: http://www.unicef.org/infobycountry/trinidad_tobago_statistics.html
Bieback K, Kern S, Kluter H and Eichler H." Critical Parameters for the Isolation of Mesenchymal Stem Cells form Umbilical Cord Blood", Stem Cells 22(2004): 625-634.
Lee O, Kuo T, Chen W, Lee K, Hsieh S and Chen T. "Isolation of multipotent mesenchymal stem cells from umbilical cord blood", Blood 103(2004): 1669-1675.
Ma K., Laco F, Ramakrishna S, Liao S and Chan C. "Differentiation of bone marrow-derived mesenchymal stem cells into multi-layered epidermis-like cells in 3D organotypic coculture", Elsevier, Biomaterials 30(2009): 3251-3258.
McCoy, J.P., Isolation of Mononuclear Cells by Density Gradient Separation, Creighton University, 1998
Iaquinta MR, Mazzoni E, Bononi I, Rotondo JC, Mazziotta C, Montesi M, Sprio S, Tampieri A, Tognon M, Martini F. Adult stem cells for bone regeneration and repair. Frontiers in cell and developmental biology. 2019 Nov 12; 7:268.
Cord Blood Registry, "Umbilical Cord Blood Collection Process." https://www.cordblood.com/banking/collection-process
Cord Blood Center, "Umbilical Cord Blood Banking: A Complete Guide." https://www.cordbloodbanking.com/umbilical-cord-blood-banking/
Wang, H. S., Hung, S. C., Peng, S. T., et al. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22(7), 1330-1337.
Dominici ML, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006 Jan 1;8(4):315-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Nicole Ramlachan, Jerome Foster
This work is licensed under a Creative Commons Attribution 4.0 International License.
